ELIZABETH LIGGETT: Open Payments
NPI 1407199425 · OKATIE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,183 in 43 payments from 11 companies in 2025. Trend: 2023 $1,635 · 2024 $1,665 · 2025 $1,183
Food & beverage: $937Education: $246
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $361 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $255 |
| Regeneron Healthcare Solutions, Inc. | 8 | $164 |
| Organogenesis Inc. | 4 | $109 |
| Novartis Pharmaceuticals Corporation | 2 | $104 |
| ABBVIE INC. | 4 | $75 |
| Galderma Laboratories, L.P. | 1 | $43 |
| Amgen Inc. | 1 | $24 |
| UCB, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
Products named: TREMFYA, DUPIXENT, ILUMYA, COSENTYX, SKYRIZI, VIA MATRIX, SIMPLIMAX, NOVACHOR.
Industry payments across SC — which companies pay providers there.
